• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代抗精神病药物治疗精神分裂症的对照、镜像研究。

A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.

作者信息

Taylor David, Hayhurst Karen, Kerwin Robert

机构信息

Pharmacy Department, Maudsley Hospital, London, UK.

出版信息

Int Clin Psychopharmacol. 2007 May;22(3):133-6. doi: 10.1097/YIC.0b013e3280148219.

DOI:10.1097/YIC.0b013e3280148219
PMID:17414738
Abstract

Second-generation antipsychotics are now treatments of choice in many countries. In this study, we aimed to compare hospital stay and admissions to hospital in patients switching from first-generation (conventional) to second-generation (atypical) antipsychotics with patients switching from one first-generation drug to another. This was a retrospective, 6-year, controlled mirror-image study conducted in an acute general psychiatry services in an inner-city area. Subjects were consisted of patients diagnosed with schizophrenia or schizoaffective disorder receiving continuous prescription of antipsychotics over at least a 6-year period between 1994 and 2002. The main outcome measures were number of days spent in hospital and number of admissions to hospital. In 36 patients switched from first to second-generation antipsychotics, total number of days spent in hospital increased, from a mean of 90 days in the 3 years before switching, to a mean of 200 days in the 3 years after (P<0.001). Mean number of admissions did not change significantly (1.61 before vs. 1.44 after, P=0.360). In 36 matched control patients, switching between first-generation antipsychotic drugs, mean number of days in hospital fell from 64 to 50 (P=0.189) and number of admissions was virtually unchanged (1.42 before vs. 1.03 after, P=0.202). Mean days in hospital were significantly increased in the second-generation antipsychotic group compared with the first-generation antipsychotic (control) group (P<0.001). Switching from first to second-generation antipsychotics resulted in an important increase in number of days spent in hospital. Switching from one first-generation antipsychotic drug to another did not significantly affect number of days in hospital.

摘要

第二代抗精神病药物如今在许多国家都是首选治疗药物。在本研究中,我们旨在比较从第一代(传统)抗精神病药物转换为第二代(非典型)抗精神病药物的患者与从一种第一代药物转换为另一种第一代药物的患者的住院时间和住院次数。这是一项在市中心地区的急性普通精神病服务机构中进行的回顾性、为期6年的对照镜像研究。研究对象包括在1994年至2002年期间至少连续6年接受抗精神病药物处方治疗的精神分裂症或分裂情感性障碍患者。主要观察指标为住院天数和住院次数。在36例从第一代抗精神病药物转换为第二代抗精神病药物的患者中,住院总天数增加,从转换前3年的平均90天增加到转换后3年的平均200天(P<0.001)。平均住院次数没有显著变化(转换前为1.61次,转换后为1.44次,P = 0.360)。在36例匹配的对照患者中,第一代抗精神病药物之间的转换使平均住院天数从64天降至50天(P = 0.189),住院次数基本未变(转换前为1.42次,转换后为1.03次,P = 0.202)。与第一代抗精神病药物(对照)组相比,第二代抗精神病药物组的平均住院天数显著增加(P<0.001)。从第一代抗精神病药物转换为第二代抗精神病药物导致住院天数显著增加。从一种第一代抗精神病药物转换为另一种第一代抗精神病药物对住院天数没有显著影响。

相似文献

1
A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.第二代抗精神病药物治疗精神分裂症的对照、镜像研究。
Int Clin Psychopharmacol. 2007 May;22(3):133-6. doi: 10.1097/YIC.0b013e3280148219.
2
[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].[法国13家精神病医院抗精神病药物的处方模式]
Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7.
3
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.早期精神病的口服与注射用抗精神病药物治疗:两项研究的事后比较
Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.
4
The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.辅助心境稳定剂对患有精神分裂症的医疗补助计划参保者的抗精神病药物使用模式及健康资源利用的影响。
Curr Med Res Opin. 2007 Jun;23(6):1351-65. doi: 10.1185/030079907X187883. Epub 2007 May 1.
5
A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.一项针对患有严重持续性精神疾病患者使用第二代抗精神病药物进行多药联合治疗的研究。
J Psychiatr Pract. 2007 Mar;13(2):129-37. doi: 10.1097/01.pra.0000265773.03756.3e.
6
Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.精神分裂症患者是否未得到充分的第二代抗精神病药物治疗?一项关于德国精神科医生处方习惯的试点研究。
Pharmacopsychiatry. 2003 Nov;36(6):309-12. doi: 10.1055/s-2003-45119.
7
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.抗精神病药物安慰剂对照和活性对照临床试验中的脱落率:一项荟萃分析。
Arch Gen Psychiatry. 2005 Dec;62(12):1305-12. doi: 10.1001/archpsyc.62.12.1305.
8
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.非典型与典型抗精神病药物治疗精神分裂症在常规护理中的有效性及成本
J Ment Health Policy Econ. 2008 Jun;11(2):89-97.
9
[Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].[长效注射用抗精神病药物与口服第二代抗精神病药物治疗的精神分裂症患者住院间隔时间对比]
Psychiatr Prax. 2007 Sep;34(6):289-91. doi: 10.1055/s-2006-951858.
10
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.新西兰精神分裂症患者氯氮平处方的治疗途径与模式
Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.